Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  73 results for ""Ubiquitin-Activating Enzymes""

Your Filters

Publication : bmc cancer
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

MARCH1 negatively regulates TBK1-mTOR signaling pathway by ubiquitinating TBK1.

  • Authors : Li X; The Second Clinical Medical College , Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.; Cheng K

Subjects: Protein Serine-Threonine Kinases*/Protein Serine-Threonine Kinases*/Protein Serine-Threonine Kinases*/metabolism ; Protein Serine-Threonine Kinases*/Protein Serine-Threonine Kinases*/Protein Serine-Threonine Kinases*/genetics ; Signal Transduction*

  • Source: BMC cancer [BMC Cancer] 2024 Jul 26; Vol. 24 (1), pp. 902. Date of Electronic Publication: 2024 Jul 26.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Expression and regulatory network of E3 ubiquitin ligase NEDD4 family in cancers.

  • Authors : Cao L; Department of Anus and Intestine Surgery, the First Affiliated Hospital of China Medical University, 155# North Nanjing Street, Heping District, Shenyang City, 110001, Liaoning Province, China.; Li H

Subjects: Ubiquitin-Protein Ligases*/Ubiquitin-Protein Ligases*/Ubiquitin-Protein Ligases*/genetics ; Ubiquitin-Protein Ligases*/Ubiquitin-Protein Ligases*/Ubiquitin-Protein Ligases*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/genetics

  • Source: BMC cancer [BMC Cancer] 2023 Jun 08; Vol. 23 (1), pp. 526. Date of Electronic Publication: 2023 Jun 08.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

BARD1 mystery: tumor suppressors are cancer susceptibility genes.

  • Authors : Hawsawi YM; King Faisal Specialist Hospital and Research Center- Research Center, KFSH&RC, MBC-J04, P.O. Box 40047, Jeddah, 21499, Saudi Arabia. .; College of Medicine, Al-Faisal University, P.O. Box 50927, Riyadh, 11533, Saudi Arabia. .

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Tumor Suppressor Proteins*/Tumor Suppressor Proteins*/Tumor Suppressor Proteins*/genetics ; Tumor Suppressor Proteins*/Tumor Suppressor Proteins*/Tumor Suppressor Proteins*/metabolism

  • Source: BMC cancer [BMC Cancer] 2022 Jun 01; Vol. 22 (1), pp. 599. Date of Electronic Publication: 2022 Jun 01.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Co-expression and prognosis analyses of GLUT1-4 and RB1 in breast cancer.

  • Authors : Zhang X; Department of Pharmacy, Base for Clinical Trial, Peking University First Hospital, No. 8, Xishku Street, Beijing, 100034, P. R. China.; Pang X

Subjects: Glucose Transporter Type 1/Glucose Transporter Type 1/Glucose Transporter Type 1/*metabolism ; Glucose Transporter Type 2/Glucose Transporter Type 2/Glucose Transporter Type 2/*metabolism ; Glucose Transporter Type 3/Glucose Transporter Type 3/Glucose Transporter Type 3/*metabolism

  • Source: BMC cancer [BMC Cancer] 2021 Sep 15; Vol. 21 (1), pp. 1026. Date of Electronic Publication: 2021 Sep 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.

  • Authors : Wang C; Department of Urinary Surgery, Gongli Hospital, Second Military Medical University (Naval Medical University), 219 Miaopu Road, Shanghai, China. .; Department of Urology, the Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, 29 Xinglong Road, Changzhou, Jiangsu, China. .

Subjects: Biomarkers, Tumor* ; Gene Expression*; Carcinoma, Renal Cell/Carcinoma, Renal Cell/Carcinoma, Renal Cell/*genetics

  • Source: BMC cancer [BMC Cancer] 2021 Aug 04; Vol. 21 (1), pp. 890. Date of Electronic Publication: 2021 Aug 04.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

MARCH6 promotes hepatocellular carcinoma development through up-regulation of ATF2.

  • Authors : Sun J; Comprehensive Liver Cancer Center, The Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.; Dong Z

Subjects: Activating Transcription Factor 2/Activating Transcription Factor 2/Activating Transcription Factor 2/*metabolism ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*metabolism

  • Source: BMC cancer [BMC Cancer] 2021 Jul 17; Vol. 21 (1), pp. 827. Date of Electronic Publication: 2021 Jul 17.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.

  • Authors : Manzano RG; Molecular Genetics and Genomics Laboratory, Unidad de Consejo Genetico, Plataforma de Oncologia, Hospital Quironsalud Torrevieja, Pda. La Loma s/n, 03184, Torrevieja (Alicante), Spain. .; Catalan-Latorre A

Subjects: Biomarkers, Tumor* ; Mutation*; Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*therapeutic use

  • Source: BMC cancer [BMC Cancer] 2021 Apr 20; Vol. 21 (1), pp. 432. Date of Electronic Publication: 2021 Apr 20.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.

  • Authors : Saurabh K; James Graham Brown Cancer Center, School of Medicine, University of Louisville, Louisville, KY, USA.; Shah PP

Subjects: Adenocarcinoma of Lung/Adenocarcinoma of Lung/Adenocarcinoma of Lung/*metabolism ; Lung Neoplasms/Lung Neoplasms/Lung Neoplasms/*metabolism ; Ubiquitin-Protein Ligases/Ubiquitin-Protein Ligases/Ubiquitin-Protein Ligases/*metabolism

  • Source: BMC cancer [BMC Cancer] 2020 Aug 31; Vol. 20 (1), pp. 824. Date of Electronic Publication: 2020 Aug 31.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

CRL4 ubiquitin ligase stimulates Fanconi anemia pathway-induced single-stranded DNA-RPA signaling.

  • Authors : Codilupi T; Institute of Pharmacology and Toxicology, University of Zurich-Vetsuisse, Winterthurerstrasse 260, 8057, Zurich, Switzerland.; Taube D

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Cisplatin/Cisplatin/Cisplatin/*pharmacology ; DNA, Single-Stranded/DNA, Single-Stranded/DNA, Single-Stranded/*genetics

  • Source: BMC cancer [BMC Cancer] 2019 Nov 05; Vol. 19 (1), pp. 1042. Date of Electronic Publication: 2019 Nov 05.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients.

  • Authors : Wahabi K; Genome Biology Laboratory, Department of Biosciences, Jamia Millia Islamia, New Delhi, 110025, India.; Perwez A

Subjects: Mutation Rate*; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*genetics ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*mortality

  • Source: BMC cancer [BMC Cancer] 2019 Aug 20; Vol. 19 (1), pp. 820. Date of Electronic Publication: 2019 Aug 20.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  73 results for ""Ubiquitin-Activating Enzymes""